Increased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer
Gema Frühbeck(Clinica Universidad de Navarra), Victoria Catalán(Instituto de Salud Carlos III), Laura Salmón‐Gómez(Instituto de Salud Carlos III), Amaia Rodrı́guez(Instituto de Salud Carlos III), Camilo Silva(Instituto de Salud Carlos III), Beatriz Ramírez(Instituto de Salud Carlos III), Sara Becerril(Instituto de Salud Carlos III), Javier Gómez‐Ambrosi(Instituto de Salud Carlos III), Jorge Baixauli(Clinica Universidad de Navarra), Víctor Valentí(Instituto de Salud Carlos III), Rafael Moncada(Instituto de Salud Carlos III), Gabriela Neira(Instituto de Salud Carlos III)
Cited by 2
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
|Diabetologia|2024|150
Ghrelin reduces TNF-α-induced human hepatocyte apoptosis, autophagy and pyroptosis: role in obesity-associated NAFLD
|The Journal of Clinical Endocrinology & Metabolism|2018|110